Search results
Results from the WOW.Com Content Network
While applying the Bayley Scales of Infant Development (BSID-II), it was found that scales may lead to under-estimates of cognitive abilities in infants with Down syndrome. [7] Researchers excluded a number of items that implicated language, motor , attentional and social functioning from the original measures the modified form was administered ...
Baroda Developmental Screening Test is a screening test for motor-mental assessment of infants, developed from Bayley Scales of Infant Development. [1] History
The Apgar score is a quick way for health professionals to evaluate the health of all newborns at 1 and 5 minutes after birth and in response to resuscitation. [1] It was originally developed in 1952 by an anesthesiologist at Columbia University, Virginia Apgar, to address the need for a standardized way to evaluate infants shortly after birth.
Lumbosacral transitional vertebrae consist of the process of the last lumbar vertebra fusing with the first sacral segment. [1] While only around 10 percent of adults have a spinal abnormality due to genetics, a sixth lumbar vertebra is one of the more common abnormalities. [2] Sacralization of the L5 vertebra is seen at the lower right of the ...
Newborn screening (NBS) is a public health program of screening in infants shortly after birth for conditions that are treatable, but not clinically evident in the newborn period. The goal is to identify infants at risk for these conditions early enough to confirm the diagnosis and provide intervention that will alter the clinical course of the ...
0-2: A score of 0-2 indicates no change in a child's status and regular rounding is acceptable. The plan of care will be continued as is. [35] 3-4: Indicates that a child's care is worsening, but they do not need immediate assistance. The plan of care may change or continued close monitoring will be initiated. [35]
Asymptomatic (or clinically silent) is an adjective categorising the medical conditions (i.e., injuries or diseases) that patients carry but without experiencing their symptoms, despite an explicit diagnosis (e.g., a positive medical test).
The Denver Developmental Screening Test was developed in Denver, Colorado, by Frankenburg and Dodds and published in 1967. [3] As the first tool used for developmental screening in normal situations like pediatric well-child care, the test became widely known and was used in 54 countries and standardized in 15. [4]